ChiFoon Chan - Synopsys President Co-CEO, Director
| SNPS Stock | USD 527.50 12.01 2.33% |
CEO
Dr. ChiFoon Chan is President, CoChief Executive Officer, Director of Synopsys Inc. Dr. Chan has served as our coChief Executive Officer since May 2012 and as our President and a member of our Board of Directors since February 1998. Prior to his appointment as our coChief Executive Officer, he served as our Chief Operating Officer since April 1997. Dr. Chan joined Synopsys in May 1990 and has held various senior management positions, including Executive Vice President, Office of the President from September 1996 to February 1998 and Senior Vice President, Design Tools Group from February 1994 to April 1997. Dr. Chan previously held senior management and engineering positions at NEC Electronics and Intel Corporationrationration. since 2012.
| Age | 68 |
| Tenure | 12 years |
| Professional Marks | Ph.D |
| Address | 675 Almanor Avenue, Sunnyvale, CA, United States, 94085 |
| Phone | 650-584-5000 |
| Web | https://www.synopsys.com |
Synopsys Management Efficiency
The company has return on total asset (ROA) of 0.0875 % which means that it generated a profit of $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2254 %, meaning that it created $0.2254 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.20 in 2024, whereas Return On Capital Employed is likely to drop 0.15 in 2024. At this time, Synopsys' Fixed Asset Turnover is comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.67 in 2024, whereas Deferred Long Term Asset Charges is likely to drop slightly above 313 M in 2024.Similar Executives
| Found 4 records | CEO Age | ||
| Todd McKinnon | Okta Inc | 52 | |
| Cole Breidenbach | Okta Inc | N/A | |
| Alexander Karp | Palantir TechnologiesInc | 57 | |
| Dev Ittycheria | MongoDB | 57 | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0875 |
Synopsys Leadership Team
Elected by the shareholders, the Synopsys' board of directors comprises two types of representatives: Synopsys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synopsys. The board's role is to monitor Synopsys' management team and ensure that shareholders' interests are well served. Synopsys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synopsys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sassine Ghazi, President CEO | ||
| Shelagh Glaser, Chief Officer | ||
| Charlie Matar, Senior Group | ||
| Chrysostomos Nikias, Independent Director | ||
| Janice Chaffin, Director | ||
| John Runkel, General Counsel and Corporate Secretary | ||
| Sudhindra Kankanwadi, Principal Accounting Officer, Vice President Corporate Controller | ||
| Deirdre Hanford, Chief Officer | ||
| Antonio Varas, Chief Officer | ||
| ChiFoon Chan, President Co-CEO, Director | ||
| Michael Sanie, VP Communication | ||
| Mercedes Johnson, Independent Director | ||
| Brian Beattie, Chief Admin. Officer and Executive VP of Bus. Operations | ||
| Ann Minooka, Chief Officer | ||
| Alessandra Costa, Senior Group | ||
| Janet Collinson, HR Officer | ||
| Jason Schmitt, General Group | ||
| Raja Tabet, Senior Group | ||
| Alfred Castino, Independent Director | ||
| Deborah Coleman, Independent Director | ||
| Paul Stravers, Principal Engineer | ||
| John Koeter, Senior Strategy | ||
| Steven Walske, Lead Independent Director | ||
| Joseph Logan, Executive VP of Sales and Corporate Marketing | ||
| Trac Pham, Chief Officer | ||
| Stephen Gregorio, CFO, Executive Vice President | ||
| Bruce Chizen, Independent Director | ||
| Erika McEnroe, Senior Counsel | ||
| Aart Geus, Co-Founder, Chairman and Co-CEO | ||
| Lisa Ewbank, Vice President - Investor Relations | ||
| John Schwarz, Independent Director | ||
| Richard Mahoney, Chief Officer | ||
| Sriram Sitaraman, Senior Officer | ||
| Roy Vallee, Independent Director | ||
| Jill Larsen, Chief Officer |
Synopsys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Synopsys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0875 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 77.34 B | ||||
| Shares Outstanding | 152.54 M | ||||
| Shares Owned By Insiders | 0.40 % | ||||
| Shares Owned By Institutions | 94.18 % | ||||
| Number Of Shares Shorted | 3.44 M | ||||
| Price To Earning | 50.25 X |
Currently Active Assets on Macroaxis
When determining whether Synopsys is a strong investment it is important to analyze Synopsys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Synopsys' future performance. For an informed investment choice regarding Synopsys Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synopsys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Synopsys Stock please use our How to Invest in Synopsys guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for Synopsys Stock analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Synopsys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synopsys. If investors know Synopsys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synopsys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.651 | Earnings Share 9.04 | Revenue Per Share 40.3 | Quarterly Revenue Growth 0.211 | Return On Assets 0.0875 |
The market value of Synopsys is measured differently than its book value, which is the value of Synopsys that is recorded on the company's balance sheet. Investors also form their own opinion of Synopsys' value that differs from its market value or its book value, called intrinsic value, which is Synopsys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synopsys' market value can be influenced by many factors that don't directly affect Synopsys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synopsys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synopsys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synopsys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.